RVMD 57.07 (+1.06%)
US76155X1000BiotechnologyBiotechnology

Revolution Medicines (RVMD) Stock Highlights

57.07 | +1.06%
2024-11-21 00:51:55
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The companys products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Statistics

Range Today
56.01 57.97
Volume Today 818.88K
Range 1 Year
20.51 62.4
Volume 1 Year 344.79M
Range 3 Year
14.08 62.4
Volume 3 Year 893.22M
Range 10 Year
14.08 62.4
Volume 10 Year 1.12B

Highlights

Market Capitalization 10.17B (large)
Floating Shares 154.3M
Current Price 57.07
Price To Earnings -16.13
Price To Revenue 11.39K
Price To Book 6.47
Earnings Per Share -3.66
Payout Ratio 0%

Performance

Latest +1.06%
1 Month +13.55%
3 Months +30.98%
6 Months +44.59%
1 Year +167.43%
3 Years +92.15%
5 Years +102.3%
10 Years +102.3%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.